新聞Myrevital acquired Concertpharma for $576M on May 26th '23.Earlier this year, Sun Pharma also announced the completion of its acquisition of Concert Pharmaceuticals.
新聞Ilumya acquired Concertpharma for $576M on Jan 26th '23.Sun Pharma this month acquired US-based Concert Pharmaceuticals for $576 million in cash aimed at accessing Concert’s experimental drug—Deuruxolitinib--a potential treatment of Alopecia Areata, a skin disease causing partial or complete loss of hair on the scalp and body.
新聞Concertpharma had issues with possible breaches of fiduciary duty and other violations of law on Jan 19th '23.Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Concert Pharmaceuticals, Inc. ("Concert" or the "Company") (NASDAQ: CNCE ), in connection with the proposed acquisition of the Company by Sun Pharmaceutical Industries Limited via tender offer.
